China Traditional Chinese Medicine Co Ltd (0570:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the China Traditional Chinese Medicine Co Ltd stock forecast from 0 analysts, the average analyst target price for China Traditional Chinese Medicine Co Ltd is not available over the next 12 months. China Traditional Chinese Medicine Co Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of China Traditional Chinese Medicine Co Ltd is Slightly Bearish, which is based on 5 positive signals and 9 negative signals. At the last closing, China Traditional Chinese Medicine Co Ltd’s stock price was HKD 4.32. China Traditional Chinese Medicine Co Ltd’s stock price has changed by +0.23% over the past week, +0.23% over the past month and +3.85% over the last year.
No recent analyst target price found for China Traditional Chinese Medicine Co Ltd
No recent average analyst rating found for China Traditional Chinese Medicine Co Ltd
Company Overview China Traditional Chinese Medicine Co Ltd
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company manufactures and sells concentrated TCM granules, health care products, and decoction pieces under the Yi Fang, Tian Jiang, and Tong Ji Tang brand names; and offers Chinese medical related healthcare solutions including Chinese medical consultation and diagnosis through offline medical institutions. It also provides manufacture and sale of TCM finished drugs under various brands, such as Medi-world, De Zhong, and Feng Liao Xing brands. In addition, the company engages in sale of medical herbs; TCM markets, advertises, and consulting; and property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is based in Wan Chai, Hong Kong. Address: Emperor Group Centre, Wan Chai, Hong Kong Read Less
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company manufactures and sells concentrated...Read More
Frequently Asked Questions About China Traditional Chinese Medicine Co Ltd (0570:HK) Stock
Stock Target Advisor's fundamental analysis for China Traditional Chinese Medicine Co Ltd's stock is Slightly Bearish.
0570:HK stock's dividend yield is 1.20%.
Our analysis grades 0570:HK stock's dividend yield at F. This means that 0570:HK stock's dividend yield is above 7% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the HK exchange.
Based on this 0570:HK may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 0570:HK's stock to indicate what its average analyst target is.
0570:HK stock's Price/Earning ratio is 15.43.
Our analysis grades 0570:HK stock's Price / Earning ratio at F. This means that 0570:HK stock's Price/Earning ratio is above 67% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the HK exchange.
Based on this 0570:HK may be a overvalued for its sector.
The last closing price of 0570:HK's stock was HKD 4.32.
The most recent market capitalization for 0570:HK is HKD 21.75B.
Unfortunately we do not have enough analyst data on 0570:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains China Traditional Chinese Medicine Co Ltd's stock.
As per our most recent records China Traditional Chinese Medicine Co Ltd has 17,303 Employees.
China Traditional Chinese Medicine Co Ltd's registered address is Emperor Group Centre, Wan Chai, Hong Kong.
You can get more information about it from China Traditional Chinese Medicine Co Ltd's website at https://www.china-tcm.com.cn.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0570:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
